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Among the animal models for studying the molecular basis of atrial and sinoatrial node 
(SAN) biology and disease, the mouse is a widely used species due to its feasibility for 
genetic modifications in genes encoding ion channels or calcium handling and signaling 
proteins in the heart. It is therefore highly valuable to develop robust methodologies for 
studying SAN and atrial electrophysiological function in this species. Here, we describe 
a protocol for performing dual calcium-voltage optical mapping on mouse sinoatrial 
preparation (SAP), in combination with an optogenetic approach, for studying SAP 
membrane potential, intracellular Ca2+ transients, and pacemaker activity. The protocol 
includes the details for preparing the intact SAP, robust tissue dual-dye loading, light-
programmed pacing, and high-resolution optical mapping. Our protocol provides an 
example of use of the combination of optogenetic and optical mapping techniques for 
investigating SAP membrane potential and intracellular Ca2+ transients and pacemaker 
activity with high temporal and spatial resolution in specific cardiac tissues. Thus, our 
protocol provides a useful tool for studying SAP physiology and pathophysiology in mice.
Keywords: sinoatrial preparation, optogenetic pacing, optical mapping, murine heart, Ca2+ transient
INTRODUCTION
The heartbeat begins in the sinoatrial node (SAN) arising in a subset of nodal cells that display 
a spontaneous diastolic depolarization (Bleeker et  al., 1980). Unique to such automaticity of the 
SAN, pacemaker cells possess “membrane clock” contributions by several membrane currents 
including the funny current, If, carried by hyperpolarization-activated cyclic nucleotide-gated (HCN) 
channels. If is initiated specifically at the initial phase of the diastolic depolarization, following 
the deactivation of outward delayed rectifier K+ current, and triggering the activation of inward 
currents. Inward currents include Na+-dependent background current; the T- and L-type Ca2+ 
currents, ICaT and ICaL; and possibly, sustained inward current, Ist (Lei et  al., 2018). However, more 
recently, intracellular signaling involving the sarcoplasmic reticulum (SR) Ca2+ stores and the 
cellular cAMP levels and consequent phosphorylation of their signaling proteins have also been 
implicated in a “Ca2+ clock” contributing to diastolic depolarization (Lei et  al., 2018). Whereby, 
spontaneous RyR2-mediated Ca2+ release may enhance electrogenic effects of the Na+-Ca2+ exchanger 
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in late diastolic depolarization (Lei et al., 2018). These SR calcium 
release events may be  triggered by calcium-induced calcium 
release following the activation of CaV1.3 calcium channels (Torrente 
et  al., 2016). The relative importance of both the “membrane 
clock” and “Ca2+ clock” in pacemaker function remains controversial.
On the other hand, sinus node dysfunction (SND) associated 
with abnormal impulse formation or propagation in the SAN 
affects ≈1  in 600 cardiac patients aged >65  years and is 
responsible for ≈50% of the 1 million permanent pacemaker 
implants per year worldwide (de Marneffe et al., 1993). Although 
SND occurs most commonly in elderly patients in the absence 
of clinically apparent accompanying cardiac disease (de Marneffe 
et  al., 1993), its pathogenesis is unclear. The development of 
novel pharmacological therapies to cure these patients relies 
on the thorough understanding of both normal physiology 
and pathophysiology of the SAN and atria.
Among the animal models for studying the basic molecular 
mechanisms of the SAN and atrial biology and disease, mice 
are widely used due to their feasibility for modifications in 
the expression of different genes that encode ion channels or 
calcium handling proteins. It is therefore highly valuable to 
develop robust methodologies and techniques for studying SAN 
and atrial electrophysiological properties.
Recent advances in the technique of optogenetics provide an 
unprecedented opportunity for defining specific cell-type function 
in a highly complex multicellular system. The technique has 
enabled control over the activity of one specific cell type while 
leaving others unaltered, with high temporal resolution and cellular 
precision. Since the first demonstrations of utility in mammalian 
neurons in 2005 (Boyden et  al., 2005), optogenetics has spurred 
immense research activity in neuroscience and has extended to 
the cardiac field over the past few years (Entcheva, 2013; 
Nussinovitch and Gepstein, 2015; Boyle et al., 2018). We recently 
deployed a cell-type specific optogenetic approach to study the 
properties of Pnmt+ cell-derived cardiomyocytes in the murine 
heart (Wang et  al., 2017). Additionally, optical mapping using 
fluorescent dyes provides exciting opportunities for high spatio-
temporal study of cellular electrophysiological events, including 
Ca2+ dynamics of the heart (Wang et al., 2017; Wen et al., 2018). 
The combination of these two technologies therefore allows 
development of unprecedented platforms for studying physiological 
events (e.g., voltage and Ca2+ signals) in a selective manner at 
high spatio-temporal resolution (O’Shea et al., 2019b).
In this manuscript, we  describe a detailed protocol for the 
use of optogenetic and optical mapping techniques for 
investigating membrane potential and intracellular Ca2+ transients 
and pacemaker activity with high temporal and spatial resolution 
in sinoatrial preparations (SAPs). The protocol can be a powerful 
tool for studying SAP physiology and pathophysiology using 
the mouse as a model system.
METHODS AND MATERIALS
Animals
Pnmt-cre mice used in this study are as described previously 
(Wang et  al., 2017). Animals used were <6  months old. 
Pnmt-cre/ChR2 mice exhibit cell-type specific expression of ChR2 
by crossing B6.Cg-Gt (ROSA)26Sortm27.1(CAG-COP4H134R/tdTomato) Hze/J strain 
(Stock no. 012567, Jackson Labs) with a Cre transgenic strain 
under the control of a Pnmt promoter (Wang et  al., 2017). 
Channelrhodopsin 2 (ChR2) was specifically introduced into 
murine cells expressing the Phenylethanolamine n-methyltransferase 
(Pnmt) gene, which encodes for the enzyme responsible for 
conversion of noradrenaline to adrenaline. The murine model 
led to the identification of a distinctive class of Pnmt-expressing 
neuroendocrine cells and their descendants (i.e., Pnmt+ cell-derived 
cardiomyocytes) within the heart (Wang et  al., 2017).
All procedures have been approved by Institutional Animals 
Ethics Committees at Southwest Medical University, Luzhou, 
China or Department of Pharmacology at University of Oxford, 
UK and the national guidelines under which the institution 
operates. All mice used in this study were maintained in a 
pathogen-free facility at Southwest Medical University or 
University of Oxford. Mice were given ad libitum access to 
food and water. The authors confirm that they have taken all 
steps to minimize the animals’ pain and suffering.
Materials and Equipment
Table 1 shows the details of materials and buffers.
Figure 1 shows the optical imaging system for light stimulation 
of ChR2 light-sensitive channels and optical recording.
The tissues were paced through the activation of ChR2 light-
sensitive channels. This was achieved by the delivery of 470 nm 
blue light pulses (13–14 ms pulse width) generated by OptoFlash 
(Cairn Research, Faversham, UK). Pulses were triggered by a 
1,401 digitizer and Spike 2 software (Cambridge Electronic 
Design). Approximate blue light intensity was measured with 
a 818-ST2 Wand Detector connected to a 843-R power meter 
(both Newport Corporation, CA, USA), and we  estimate an 
average irradiance in our experiments of 0.1–0.3  mW/mm2 
based on an approximate distance of 1–2  cm between Sylgard 
and liquid light guide (Oriel instruments Model No. 77525).
TABLE 1 | Details of materials and buffers.
Chemical and catalogue reference Supplier
NaCl (SLBS2340V) Sigma-Aldrich, St Louis, MO, USA
NaHCO3 (SLBX3605) Sigma-Aldrich
NaH2PO4 (BCBW9042) Sigma-Aldrich
KCl (SLBS5003) Sigma-Aldrich
MgCl2 (BCBS6841V) Sigma-Aldrich
CaCl2 (SLBK1794V) Sigma-Aldrich
Glucose (SLBT4811V) Sigma-Aldrich
HEPES (W1122DO10) Sangon biological Shanghai, China
2,3-butanedione monoxime (BDM) (29297) Sigma-Aldrich
Blebbistatin (SLBV5564) Tocris Bioscience Minneapolis, 
MN, USA
Voltage-sensitive dye RH237 (1971387) Thermo Fisher Scientific, Waltham, 
MA, USA
Calcium indicator Rhod-2 AM (1890519) Invitrogen, Carlsbad, CA, USA
Dimethyl sulfoxide (DMSO) (RNBT7442) Sigma-Aldrich
Heparin Sodium (H51021209) Chengdu Haitong Pharmaceutical 
Co. Ltd. Chengdu, China
Avertin (2,2,2-tribromoethanol) Sigma-Aldrich Poole, Dorset, UK
Pluronic F127 (1899021) Invitrogen, Carlsbad, CA, USA
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Buffer Compositions
Physiological Salt Solution
Freshly prepared physiological salt solution (PSS) containing 
in mM: NaCl 119, NaHCO3 25, NaH2PO4 1.0, KCl 4.7, MgCl2 
1.2, CaCl2 1.35, and glucose 10; equilibrated with 95% O2/5% 
CO2 at 37°C, pH  =  7.35.
Dye Loading Solution
Calcium indicator Rhod-2 AM  (Invitrogen, Carlsbad, CA, 
USA) was dissolved in dimethyl sulfoxide (DMSO, Sigma-
Aldrich, St. Louis, MO, USA) to prepare a stock concentration 
of 10  mg/ml (8.9  mM). The voltage indicator stock was 
prepared by dissolving Di-4-ANBDQPQ (University of 
Connecticut Health Center) in ethanol to obtain a stock 
concentration of 29  mM. To avoid repeated freezing and 
thawing, both stocks were stored in 50  μl aliquots at −20°C. 
For working concentrations of Rhod-2 AM  dye loading 
solution, 15  μl Rhod-2 AM  stock solution was mixed with 
15  μl Pluronic F-127 (20% solution in DMSO, Invitrogen, 
Carlsbad, CA, USA) and then dissolved in 15 ml PSS (10 μM 
final concentration). Similarly, 5.2  μl of Di-4-ANBDQPQ 
stock was mixed with 15 μl Pluronic F-127 and then dissolved 
in 15  ml PSS to form a working concentration of Di-4-
ANBDQPQ dye loading solution (10 μM final concentration). 
The working dye loading solutions were prepared on the 
day of the experiment.
Blebbistatin Physiological Salt Solution
Excitation-contraction uncoupler blebbistatin (Invitrogen, 
Carlsbad, CA, USA) was dissolved in in DMSO (Sigma-Aldrich, 
St. Louis, MO, USA) to make up 10  mM stock solution. To 
avoid repeated freezing and thawing, aliquots of 15  μl were 
stored at −20°C. A 10  μl of 10  mM stock blebbistatin solution 
was added to 15  ml PSS to make blebbistatin PSS solution 
(10  μM final concentration).
Preparation and Equipment
 1. Dissection set-up includes stereomicroscope, dissection 
chamber filled with Sylgard gel, oxygenation device, LED 
light source, and surgical instruments.
 2. The optical mapping system was set up as detailed below:
A custom-designed system equipped with an EMCCD 
camera (Evolve 128, Photometrics, Tucson, AZ, USA) was 
used (see Figure 1). Two green (to excite Ca2+ sensitive 
dye Rhod-2 AM; a peak wavelength of 530  nm) and two 
red (to excite the voltage sensitive dye Di-4-ANBDQPQ; 
a peak wavelength of 627  nm) LED lights (Cairn Research, 
Faversham, UK) were placed around the imaging chamber 
so as to uniformly illuminate the SAP. The green LEDs (peak 
wavelength  =  530  nm) were fitted with excitation bandpass 
filters (S555/25X, Chroma Technology GmbH, Germany), 
and the red LEDs (peak wavelength  =  627  nm) were fitted 
with excitation bandpass filters (HQ640/50, Chroma 
Technology GmbH, Germany) to efficiently select optimal 
excitation wavelength range for Rhod-2 AM  and Di-4-
ANBDQPQ, respectively. A multi-bandpass emission filter 
(ET595/50  +  700LP, Chroma Technology GmbH, Germany) 
was placed in front of the camera lens to avoid bleed-through 
of the excitation light and to selectively let the fluorescence 
emission to pass through. CaT (calcium transient) and 
transmembrane potential (Vm) measurements were taken at 
high resolution (128  ×  128 pixels; pixel size 66  ×  66  μm) 
at a rate of 520 frames/s.
FIGURE 1 | The optical imaging system. Two green (a peak wavelength of 530 nm) and two red (a peak wavelength of 627 nm) LED lights (Cairn Research, 
Faversham, Kent, UK) were placed around the chamber so as to uniformly illuminate the SAP. The green LEDs were fitted with excitation bandpass filters (S555/25X, 
Chroma Technology GmbH, Germany), and the red LEDs were fitted with excitation bandpass filters (HQ640/50, Chroma Technology GmbH, Germany) to efficiently 
select the best excitation wavelength range for Rhod-2 AM and Di-4-ANBDQPQ, respectively. A multi-bandpass emission filter (ET595/50 + 700LP, Chroma 
Technology GmbH, Germany) was placed in front of the camera lens to avoid bleed-through of the excitation light and to selectively let the fluorescence emission 
pass through. A multi-stream light switcher (Cairn Research, Faversham, Kent, UK) was set up to automatically switch between the red and green LED lights in 
accordance with the frame rate of the camera. Signal recording using this setup is in such a way that one frame data recorded will have only the red light turned on 
(thereby recording voltage signal alone) and the next frame data recorded will have only the green light turned on (thereby recording CaT signal alone), and the 
process is repeated until the desired number of frames are recorded.
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PROTOCOL
Harvest the Mouse Heart and Prepare the 
Sinoatrial Preparation (30 min)
The steps for preparation of the SAP are outlined in Figure 2 
and as described previously (Liu et  al., 2007; Hao et  al., 2011; 
Sharpe et  al., 2016). The details are as follows:
 1. Non-recovery terminal general anesthesia was induced by 
injection of an overdose of 1.2% Avertin solution 
(0.5–0.8 ml i.p., 2,2,2-tribromoethanol, Sigma-Aldrich, Poole, 
Dorset, UK), followed by intraperitoneal injection with 
heparin (200  units).
 2. Following sacrifice via cervical dislocation, the heart was 
rapidly excised and placed in warmed (37°C) and oxygenated 
(95% O2 + 5% CO2 gas) PSS solution in a dissection chamber.
 3. The heart was gently pressed with the tips of fingers to 
push the blood out of heart. Fresh oxygenated PSS was 
then added for further dissection.
 4. SAP containing two atria and the SAN region was dissected 
after clearing off the lung, thymus, ventricles, and connective 
tissues (Figure 2B).
 5.  The right atrium was opened from atrioventricular (AV) 
junction to expose the intercaval region containing the SAN, 
following which left atrium was opened to expose the left 
atrial endocardium. As the pacemaker cells are widely 
distributed throughout the entire region located between 
the superior (SVC) and inferior vena cava (IVC) and between 
the crista terminalis and intra-atrial septum (Glukhov et al., 
2010), the SAP contains the SAN and the two atria intact.
 6. The SAP was pinned onto a small rectangular piece of 
Sylgard gel by using fine insect pins. All dissection steps 
were performed in a dissection chamber with oxygenated 
PSS solution under a stereomicroscope.
Dual Dye Loading of the Sinoatrial 
Preparation (25 min)
 7.  A 50  ml falcon tube was filled with 15  ml of the Rhod-2 
AM  dye loading solution.
 8.  The Sylgard gel (with SAP attached) was then dropped 
into the falcon tube.
 9.  The SAP-containing falcon tube was placed in a 36°C water 
bath. The solution was oxygenated constantly by gently 
bubbling with 95% O2/5% CO2 (Note: heavy bubbling can 
lead to the formation of foam due to the presence of 
Pluronic F-127  in the solution. This can lead to the 
suboptimal dye loading). The SAP was incubated in the 
dye loading solution for 15  min.
 10.  Dual dye loading of the SAP was performed by incubating 
the SAP in Rhod-2 AM  dye loading solution as detailed 
above (points 7–9), following which the Sylgard gel with 
SAP attached was transferred into a new 50  ml falcon tube 
containing 10  μM Di-4-ANBDQPQ dye loading solution. 
Incubation with Di-4-ANBDQPQ was performed for 10 min 
at 36°C and constantly bubbled with 95% O2/5% CO2.
Optical Mapping (30 min)
 11.  The imaging chamber was filled with 15  ml of blebbistatin 
PSS solution and was placed directly under the camera. 
The recording chamber was heated up to 36°C by a 
heating plate.
 12.  The Sylgard (with SAP attached) was removed from the 
falcon tube and pinned down in the imaging chamber. The 
sample was placed between the two field-stimulation electrodes. 
(Note: Removing the SAP from the Sylgard and pinning 
down directly in the chamber cause further damage to the 
SAP. Therefore, pinning down the Sylgard with the intact 
A a b
B
FIGURE 2 | The isolation of mouse SAP. (A) The setup of dissection. (a) The dissection was performed under the stereomicroscope and oxygenated PSS solution. 
(b) Surgical instruments. (B) The preparation of SAP. RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; SAN, sinoatrial node; AV junction, 
atrioventricular junction, SET = septum, SVC = superior vena cava, IVC = inferior vena cava, CT = crista terminalis.
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tissue is recommended). The blebbistatin PSS solution was 
bubbled in the imaging chamber with 95% O2/5% CO2 gas.
 13.  Imaging was performed after cessation of motion by 
blebbistatin. Imaging used the EMCCD camera controlled 
by the acquisition software Metamorph (Molecular Devices). 
During image recordings, the excitation lights were turned 
on, and bubbling was temporarily stopped (to avoid distortion 
of the signals due to bubbles and motion of the solution). 
Since Pnmt+ cell-derived cardiomyocytes (PdCMs) express 
channelrhodopsin-2 (ChR2), they can be excited by exposure 
to 470  nm blue light. The stimulation protocol was then 
run, and baseline calcium transient or action potential 
recordings were taken. Recordings were taken again after 
stimulating the left atrium using blue light (pacing intervals: 
150–160 ms, pulse duration: 13–14 ms, intensity: 1,992 mA). 
The frame rate of these recordings was 0.52  kHz.
 14.  For dual dye imaging, a multistream light switcher (Cairn 
Research, Faversham, Kent, UK) was set up to automatically 
switch between the red (627  nm) and green (530  nm) 
LED lights according to the frame rate of the camera. 
Signal recording using this setup was performed, so that 
one frame of the data was recorded under red light 
illumination (thereby recording Vm signal alone), and the 
next frame was recorded under green light illumination 
(thereby recording CaT signal alone) and so forth until 
the desired number of frames was recorded. This resulted 
in an interlaced signal containing alternate frames of CaT 
and Vm signals. The interlaced signal was separated into 
CaT and voltage signal using ImageJ and saved as separate 
files. Due to the signals being interposed, the frame rate 
recording was 0.26  kHz.
Analysis
 15.  The saved image files were loaded, processed, and analyzed 
using the optical mapping analysis software ElectroMap 
(developed by Dr. Pavlovic’s group, https://github.com/
CXO531/ElectroMap; O’Shea et  al., 2019a).
 16.  Images were pre-processed by applying a 4 × 4 pixel Gaussian 
spatial filter (standard deviation = 1.5), a Top-Hat baseline 
correction (kernel size = 100 ms), and a third order Savitzky-
Golay temporal filter. A window size of 40  ms before 
transient peak to 100 ms after transient peak was used. 
Action potential duration (APD) and CaT duration (CaD) 
were measured at the desired repolarization/decay percentage 
at each pixel across the tissue, as measured from time of 
maximum upstroke velocity (maximum dF/dt).
 17.  For assessment of local conduction velocities, activation 
maps were generated using time of depolarization midpoint. 
Conduction velocity across the SAP was then quantified 
using a multi-vector polynomial method (Bayly et al., 1998) 
with a local window size of 5  ×  5 pixels.
 18.  To further assess conduction across the entire SAP, 
we  used activation curve analysis, where the percentage 
of tissue activated was plotted as a function of time 
(O’Shea et  al., 2019a).
Representative Results
A typical example of an SAP Ca2+ transient activation map 
reconstructed from spontaneous sinus rhythmic Ca2+ transients 
(by Rhod-2 AM) recorded with the optical mapping system 
is shown in Figure 3A for a SAP. The early activation point 
is located within the intercaval region near to where the 
SAN is located. However, as shown in Figure 3B, the calcium 
activation pattern and atrial conduction changed after 
stimulating with blue light (interval: 150 ms; duration: 13 ms; 
intensity: 1,992  mA; pulses per train: 50). The leading 
pacemaker site was shifted to the location of left atrium, 
suggesting that PdCMs were activated earlier than the SAN 
pacemaker cells. This is consistent with our previous report 
that PdCM cells predominantly localized to the left atrium 
and left ventricle, and the heart rate was controlled by 
stimulating PdCMs selectively with blue light (Wang et  al., 
2017). We  hypothesize that PdCM cells overexpressing ChR2 
may be  a viable site for spatially-targeted optical pacing 
when sinus node pacemaker cells are dysfunctional. Further 
A B
FIGURE 3 | The change of atrial conduction in optogenetic mice during after blue light stimulation. Maps produced by mapping the midpoint time of the  
CaT rise. (A) Ca2+ transient activation map during intrinsic pacing, before optical pacing. (B) Ca2+ transient activation map during optical pacing with blue 
(470 nm) light pulses.
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investigation is required. Figure  4 shows representative Vm 
and CaT maps and voltage and calcium traces from different 
regions of the SAP, illustrating the robustness of this preparation 
for murine research. We  monitored the “rundown” of the 
Vm and CaT signals for up to 4  h – the average signal 
“rundown” is less than 25%. Our experiment usually finished 
within 3  h from the beginning of Langendorff perfusion of 
the heart. We  again observe augmentation of the activation 
pattern induced by optical pacing, shown by both the voltage 
(Figure 4, upper panel) and calcium (Figure 4, lower panel) 
activation maps. Activation maps were produced by mapping 
the midpoint time of the AP/CaT rise.
We found that optogenetic pacing of a SAP can shift the 
activation point to the left, creating a new leading pacemaker 
site or “neonode.” Activation patterns in the SAP were plotted 
using ElectroMap (O’Shea et  al., 2019a), with the midpoint of 
the upstroke of the calcium transient used as a pixel-by-pixel 
readout of tissue activation. The earliest-activating pixel—
discarding outliers—was designated the activation point for that 
tissue. The earliest activation point before pacing was always 
in the nodal region. Optogenetic pacing of PdCMs can move 
this activation point to the left (Figure 5), establishing a new 
leading pacemaker site toward the left atrium. This change in 
the location of the leading pacemaker is reversible upon cessation 
of pacing (Figures 5A,E). Left shift of the leading pacemaker 
occurred in four of seven SAPs (Figure 5D). One leftward 
deviation appears more upward relative to the SVC-IVC axis—
this is due to contortion of the tissue. Although no leading 
pacemaker shift occurred in three SAPs, all seven SAPs were 
successfully paced by blue light: with a decrease in mean cycle 
length from 264.3  ±  42.7  ms before optogenetic pacing to 
159.2  ±  1.4  ms during (p  <  0.02). Mean cycle length after 
pacing was 281.9  ±  48.9  ms—not significantly different from 
before (p  =  0.63). Therefore, we  can always successfully and 
reversibly pace PdCMs using selective ChR2 overexpression. 
The variability in pacemaker shift observed (Figure 5D) is 
consistent with the variable distribution of murine PdCMs across 
both the SAN region and the left atrium (Ni et  al., 2017; Wang 
et  al., 2017). In summary, we  report the possibility of using 
optogenetic pacing of PdCMs to establish novel left-shifted 
leading pacemaker sites in the murine heart.
To study the effects of optogenetic pacing on overall conduction, 
we  utilized activation curve analysis where the percentage of 
tissue activated is plotted as a function of time (O’Shea et  al., 
2019a). Optogenetic pacing of PdCMs augments conduction in 
the SAP—producing a left shift of the activation curve (Figure 6A). 
This is most noticeable in the first few milliseconds of tissue 
activation (Figure 6A, inset). During optogenetic pacing, the 
rate of tissue activation is initially very rapid (Figure 6B, inset), 
otherwise, there are no major alterations to tissue activation 
rate (Figure 6B). Optogenetic pacing reduces the time to 5% 
tissue activation from 1.59  ±  0.24 to 0.88  ±  0.17  ms (p  =  0.03), 
FIGURE 4 | Simultaneous voltage (top panels) and Ca2+ transient (bottom panels) activation maps reconstructed from spontaneous sinus rhythmic (left panels) and 
light paced (right panels) SAP. Maps were produced by mapping the midpoint time of the voltage and CaT rise with examples of voltage and Ca2+ transient traces 
from indicated regions of the preparation (white and red cross).
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the time to 10% tissue activation from 2.40  ±  0.25 to 
1.46 ± 0.26 ms (p = 0.02), and the time to 20% tissue activation 
from 3.91  ±  0.52 to 2.27  ±  0.33  ms (p  =  0.02) (Figure 6C), 
but at all points ≥30% tissue activation, there is no significant 
difference in activation time (Figures 6A,B).
We also wanted to explore whether the normal conduction 
pathways in the tissue remained intact during optogenetic pacing. 
Using ElectroMap, we computed local conduction velocities using 
the multi-vector method (Bayly et  al., 1998) with a 5  ×  5-pixel 
grid size. The magnitude of conduction velocity vectors 
(Figure 6D) did not change significantly with optogenetic pacing 
from 26.9  ±  3.3 before to 28.6  ±  2.5  cm/s during pacing 
(p = 0.34), and there were no major changes in the directionality 
of conduction vectors either (Figure 6E). In summary, we report 
the possibility of establishing a novel left-shifted leading pacemaker 
site, with only minimal, controlled disturbance to normal tissue 
activation rate, and little or no disturbance to the pathways 
along which conduction normally propagates.
A
B
C D
E
FIGURE 5 | Mapping of activation in SAPs under sinus rhythm and under optogenetic pacing. (A) (i ) Representative SAP—camera view. (ii ) Activation map for this 
SAP before optogenetic pacing. (iii ) Activation map during pacing (note formation of “neonode”, white asterisk). (iv) Activation map after pacing. Activation maps are 
calculated from Ca2+ transients. Fifty pacing spikes given, at 6.67 Hz. Contours drawn at 1/frame rate of the EMCCD. Scale bar, right. (B) 3-D graphical rendering of 
activation maps (i) before pacing, (ii ) during pacing. SVC-IVC axis in red. Activation time on z-axis. (C) Representative SAP—microscope view. Pacemaker shift 
overlaid. SVC-IVC axis shown. Distances in mm. (D) SVC-IVC axis with relative pacemaker shifts plotted (n = 7). (E) Mean change in “shiftedness.” LA, left atrium; 
RA, right atrium; SAN, sinoatrial node; SVC, superior vena cava; IVC, inferior vena cava; SEP, septum; NeoN, neonode.
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We  found small alterations to calcium cycling in our tissues, 
but for the most part, there was no significant change in the 
characteristics of calcium transient rise time, calcium transient 
duration to 50% of the decay (CaD50), and calcium transient 
duration to 75% of the decay (CaD75) with optogenetic pacing.
We measured the rise time, calcium transient duration to 50% 
of the decay (CaD50), and calcium transient duration to 75% 
of the decay (CaD75) as illustrated in Figure 7A. Rise time is 
a measure of upstroke duration, calculated between 10 and 90% 
of time to peak, which minimizes analytical uncertainty (Choi 
and Salama, 2000; Jaimes et  al., 2016). We  used a mixed-effects 
model, with Tukey’s post hoc tests where required, to examine 
whether there were any significant effects of optogenetic pacing. 
For rise time, there was a significant overall effect of optogenetic 
pacing (p  <  0.0001). Post hoc testing revealed that there was no 
significant effect of pacing on rise time in the right atrium or 
in the neonodal regions—but in the left atrium, rise time fell 
from 17.21  ±  0.94  ms before pacing to 15.24  ±  1.14  ms during 
pacing (p < 0.002) and rose again after pacing to 18.60 ± 1.00 ms 
(p  <  0.05, during vs. after) and in the nodal region, rise time 
fell from 17.48  ±  1.03 to 15.24  ±  1.14  ms (p  <  0.03) and rose 
again after pacing to 18.44 ± 0.95 ms (p = 0.02, during vs. after). 
In both regions, there was no significant difference between the 
before and after conditions (left atrium: p  =  0.39; nodal region: 
p = 0.61)—so the reduction in rise time with optogenetic pacing 
is reversible upon cessation of pacing (Figure 7B). There was 
no overall significant effect of optogenetic pacing on either CaD50 
(p  =  0.15) or CaD75 (p  =  0.34; Figures 7C,D). In summary, 
rise time is shorter in the left atrium and in the SAN region 
during optogenetic pacing, and this is a reversible change. 
Otherwise, calcium handling in the murine SAP appears to 
be  only marginally affected.
DISCUSSION
The success in obtaining high quality Vm and Ca2+ mapping 
results in SAPs requires several important technical 
considerations, including high consumption of oxygen and high 
sensitivity to temperature and pH of the nodal tissue. 
Furthermore, the dense arrangement of nodal cells combined 
with the significant presence of connective tissue makes it 
hard for a Ca2+ dye to reach to the nodal and atrial cells. 
The critical steps include as follows:
A B
C
D E
FIGURE 6 | Conduction pattern in the tissue under sinus rhythm and during optogenetic pacing. (A) Grouped activation curve showing mean % tissue activated 
over the time elapsed during a Ca2+ transient. SEM denoted by shading. Inset: zoomed section of first 5 ms. (B) Rate of change of % tissue activation plotted 
against time. Inset as above. (C) (i ) Time to 5% tissue activation. (ii ) Time to 10% tissue activation. (iii ) Time to 20% tissue activation. (D) Mean magnitude of local 
conduction vectors. (A–D) n = 7 throughout. (E) Representative radar plot, showing local conduction vector directionalities. Angles binned into groups of 10°—so 
0° ≤ x < 10° becomes 5°, 10° ≤ x <°20° becomes 15°, and so on. Concentric circles represent increasing frequency of vectors at that angle.
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Tissue Preparation
Intact SAPs were micro-dissected as described previously (Ju 
et  al., 2015). The SAN region was identified from anatomical 
landmarks, including the superior vena cava, the crista terminalis, 
and the interatrial septum. The tissue needs to be  oxygenated 
constantly. At this point, temperature is not critical.
Dye Loading
The Ca2+-sensitive dye used to load the SAP tissue was Rhod-2 
AM, a dye in the acetoxymethyl ester form. Esterification of 
the fluorescent molecule (Rhod-2 AM) results in an uncharged 
molecule that can permeate cell membranes and chelate cytosolic 
Ca2+. A 100-fold increase in the molecule’s fluorescence intensity 
results from Ca2+ chelation (Choi and Salama, 2000). The 
voltage sensitive dye used was Di-4-ANBDQPQ, due to its 
favorable spectral properties for use with Rhod-2 AM. In our 
experiments, dye loading was carried out by incubating the 
tissue in a solution consisting of Pluronic F-127 dissolved in 
DMSO. Pluronic F-127 was incorporated into the dye loading 
solution to better disperse the dye into the physiological solution. 
Dye loading was observed to be  generally better in younger 
mice than old, which may be  related to connective tissue 
making up a smaller volume of the node.
The SAP’s repetitive contractions may have disrupted dye 
loading and/or aided the leaking of the dye out from the 
tissue, making it a challenge to optimize dye loading conditions. 
A fluorescent dye that diffuses across the cell membrane well 
can also exit from the cytoplasm at a high rate. Reagents like 
probenecid help prevent this to an extent. Combining these 
with optimized temperatures, timings and oxygen supply are 
necessary for effective loading of the tissue with dye.
Optical Imaging
During imaging, motion artifacts caused disruption in the 
measurement of optical signals. Hence, to reduce contraction of 
the tissue, blebbistatin was used. Blebbistatin is an inhibitor of 
the adenosine triphosphatases associated with class II isoforms 
of myosin (Allingham et  al., 2005). This compound has been 
identified as an effective excitation-contraction uncoupler, and 
previous investigators have used it at several different concentrations 
(Fedorov et al., 2007). The use of blebbistatin at 10 μM appeared 
to effectively abolish any motion artifact due to contraction of 
the SAP without harming SAP.
Pnmt+ Cell-Derived Cardiomyocytes 
(PdCMs) and Biopacemaking Strategies
The advent of cardiac optogenetics has facilitated the identification 
of a new cardiomyocyte subpopulation in the murine heart, 
phenylethanolamine-N-methyl transferase Pnmt+-derived 
cardiomyocytes (PdCMs; Wang et  al., 2017). Through selective 
A B
C D
FIGURE 7 | (A) Characteristics of Ca2+ transients recorded from different regions under sinus rhythm and optogenetic pacing. Representative Ca2+ transient 
illustrating rise time; CaD50 (Ca2+ transient duration to 50% of the decay); and CaD75 (Ca2+ transient duration to 75% of the decay). CaD50 and CaD75 are 
calculated from max. dF/dt (max. upstroke) as detailed in the protocol. (B) Mean rise time, before (n = 7), during (n = 7), and after (n = 6) optogenetic pacing. Key at 
center. Grouping is by region: LA, left atrium; RA, right atrium; NeoN, neonodal region (n = 4); SAN, nodal region. (C) Mean CaD50 values, no overall significant 
effect of optogenetic pacing. (D) Mean CaD75 values, no overall significant effect of optogenetic pacing.
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manipulation of these cells using optogenetics, our study 
demonstrated how optogenetics can be  used to target specific 
cardiomyocyte subpopulations, overcoming many of the issues 
associated with traditional electrophysiological techniques. 
Selectively stimulating PdCMs with rhythmic blue (470  nm) 
light pulses was sufficient to maintain sinus rhythm in murine 
atria, supporting previous observations from whole heart studies 
(Wang et  al., 2017). It has also been found previously that 
the left atrium alone – dissected out– can be  paced by light 
(Wang et  al., 2017), but a capacity to optogenetically control 
the SAP has not been tested before.
The observation that a “neonode” is typically set up toward 
the left is consistent with previous findings that PdCMs occupy 
a left-sided distribution in murine heart (Wang et  al., 2017). 
We therefore assessed the effect of pacing on left atrial activation. 
Optogenetic pacing of PdCMs leads to alterations in the 
conduction pattern across murine atria. We  found (Figure 5) 
that optogenetic pacing of Pnmt-cre/Ai27D SAPs can often 
set up new sites of earliest activation (“neonodes”) toward the 
left of the tissue. Our proof-of-principle studies clearly 
demonstrate feasibility of optogenetic control of heart rate via 
the specific cell population. Indeed, in four of seven SAPs, 
we observed “neonode” formation, with the leading pacemaker 
shifting toward the left atrium. Lack of leftward shift in three 
of seven preparations may be  due to the heterogeneity in cell 
numbers and clustering of the Pnmt cells in the SAPs, thus 
altering sink-source properties of the myocardium. While the 
physiological consequences of the studies presented here 
(specifically using Pnmt cells) are not immediately clear, 
application of such approaches is of interest to the community 
and may lead to important findings on the consequences of 
the spatial shift in the leading pacemaker.
As recently reviewed by Boyle et  al. (2018), initial work in 
this area assessed possibility to override the intrinsic pacing 
frequency of a beating heart using optical stimuli. Bruegmann 
et  al. (2010) explored this question in a preclinical model by 
generating ChR2+ transgenic mice. They showed in an open-
chest configuration that pulses of light from a focused light 
source could be  used to maintain ventricular activation at rates 
faster than intrinsic sinus rhythm. Light-induced wavefronts 
were initiated from different parts of the heart (e.g., atrial or 
ventricular sites). Remarkably, the authors found that 1:1 capture 
could be  maintained when the illuminated area was small 
(0.05  mm2, ∼50 myocytes), suggesting that optogenetic pacing 
via a small population of cells is possible and robust. Several recent 
studies also provided evidence for the development of optogenetic 
defibrillating device for termination of tachyarrhythmias (Nyns 
et  al., 2016; Bruegmann et  al., 2017). Bruegmann et  al. (2017) 
reported optogenetic termination of atrial tachyarrhythmia in 
intact hearts from transgenic as well as wild-type mice ex and 
in vivo. Thus, they suggested that their report could lay the 
foundation for the development of implantable devices for pain-
free termination of AF. Nyns et  al. (2016) demonstrated that 
forced expression of a light-gated depolarizing ion channel 
(ReaChR) in the adult rat heart allows contact- and shock-free 
termination of VTs through brief local illumination of the 
ventricular surface, i.e., without relying on conventional drugs, 
tissue ablation, or electroshocks. Both mono- and polymorphic 
VTs could be  terminated in an effective and repetitive manner 
by a light-induced electrical current driven by natural 
electrochemical gradients, providing proof-of-concept for 
biological arrhythmia termination. Our study also provides 
proof-of-concept evidence supporting the development of light-
based pacing devices targeted to a particular cellular population.
Limitations of the Protocol
There are a number of possible limitations in this protocol 
including: (1) possibility of injury during the dissection of the 
preparation; (2) effectiveness of dye loading may vary between 
preparations, thereby affecting the results; and (3) partial 
uncoupling (reduction in conductance) due to the use of 
blebbistatin, which could increase the regional differences in 
Ca2+ dynamics in SAPs.
Conclusions and Future Directions
Here, we  have described a detailed protocol for dual optical 
mapping of murine SAPs with optogenetic pacing. Combination 
of high-resolution optical imaging with cell-specific optogenetic 
stimulation allows unique spatial control and study of 
electrophysiology of the SAP, not possible with traditional direct 
or field electrode techniques. In the present protocol, we  have 
demonstrated this principle with PdCMs; however, the protocol 
can be  valuable for any mouse models that cell specifically 
express opsins such as ChR2 within the sinoatrial region of 
the heart. Therefore, such an approach represents a powerful 
tool for enhanced electrophysiological understanding of 
supraventricular physiology and pathophysiology.
Future improvements may focus on exploring dual dye 
imaging and improved image processing software. Higher 
resolution and novel optical imaging modalities for 3D optical 
mapping are also important future directions of optical mapping.
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